Cat on a Hot Twin Proof? After Cougar, Puma Roars

Puma Biotechnology Inc.'s CEO Alan Auerbach first became widely known in 2009 for the sale of his previous firm, Cougar Biotechnology Inc., to Johnson & Johnson for $970 million, based largely on the strength of Cougar's lead compound, abiraterone.